Trial Profile
Drug interaction trial of BMS 986094 and simeprevir.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2012
Price :
$35
*
At a glance
- Drugs BMS 986094 (Primary) ; Simeprevir
- Indications Hepatitis C
- Focus Pharmacokinetics
- 23 Aug 2012 Status changed from planning to discontinued prior to enrolment.
- 23 Apr 2012 New trial record